Squamous Cell

A 20-gene signature prediction demonstrated high accuracy in diagnosing metastasis risk in patients with cutaneous squamous cell carcinoma, according to a study.

Single-cell RNA-sequencing and spatial transcriptomics may be able to identify tumor-specific keratinocyte subpopulations that mark aggressive squamous cell carcinoma in at-risk patients, according to a review.

Organ transplant recipients diagnosed with cutaneous squamous cell carcinoma are more likely to experience recurrence, metastasis and death from this cancer compared with non-organ transplant recipients, according to a study.

Last week, the FDA issued a safety communication stating that it has identified cases of squamous cell carcinoma in scar tissue that formed around breast implants.

While most Mohs surgeons agree on diagnostic differentiations between actinic keratosis and squamous cell carcinoma in situ, variability exists in the interpretation of in situ carcinoma on histological frozen sections, according to a study.

Due to the lack of clarity in literature, widespread implementation of consensus recommendations for actinic keratoses and cutaneous squamous cell carcinoma is needed, according to a study.

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

Atezolizumab plus a modified docetaxel, cisplatin and 5-fluorouracilregimen is a safe and effective first-line treatment for locally advanced squamous cell anal carcinoma, according to research presented at 2022 ASCO Annual Meeting.